Introduction In the domain of oncology, immunotherapy has emerged as a pioneering methodology, harnessing the body's immune system to combat malignant tumors. There are many immunotherapeutic approaches, but Chimeric Antigen Rece..
Introduction Cytokine Release Syndrome (CRS) is an immune system overreaction triggered by therapies like immunotherapy or CAR-T cell treatment. It prompts an influx of cytokines, causing symptoms ranging from fever to potentiall..
Pasien yang menjalani terapi sel T CAR rawat jalan untuk kanker harus dirawat oleh tim multidisiplin yang mencakup koordinator perawat, menurut poster yang dipresentasikan pada Konferensi Masyarakat Keperawatan Onkologi Tahunan ke-49. ..
Introduction CAR T cell therapy, an innovative form of immunotherapy, has demonstrated exceptional efficacy in the treatment of specific tumors by leveraging the potency of a patient's own immune system. Recently, scientists have..
Feb 2024: China's pioneering efforts in creating breakthrough cancer therapeutics have gained traction with the introduction of chimeric antigen receptor (CAR)-engineered T-cell (CAR T) therapy for multiple myeloma, a devastatin..
Discover the magic of CAR-T treatment! Read our blog on patient selection for CAR T therapy. Are you the ideal candidate for this innovative cancer treatment? Find out and begin your personalized journey to cancer recovery. He..
The revolutionary CAR T Cell Therapy is changing the scenario of how we deal with cancer, making it more personal and powerful. This latest therapy uses a patient's own immune cells and genetically modifies them to target and des..
Mei 2023: Terapi sel T reseptor antigen chimeric (CAR) adalah pengembangan inovatif di bidang terapi kanker individual. Sel-T milik pasien dimodifikasi secara genetik selama proses pembuatan untuk mengekspresikan...
Maret 2023: Bab pertama memoar Sam Neill akan menjadi kejutan yang luar biasa bagi seseorang yang tidak mengetahuinya sebelumnya. Ini dimulai cukup lucu: utas besar tentang putrinya Elena ditanyai tentang jo..
Maret 2023: Ringkasan Singkat: Tujuan dari uji klinis ini adalah untuk mengetahui apakah terapi sel T CAR reseptor antigen anti-MESO dapat digunakan untuk mengobati kanker ovarium epitel yang telah kambuh atau berhenti merespons penyakit lain..